| Date Filed | Type | Description |
| 10/03/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,038 shares
@ $827, valued at
$858.4k
Exercised 1,038 options to buy
@ $372.46, valued at
$386.6k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 250 shares
@ $744.66, valued at
$186.2k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 250 shares
@ $710.09, valued at
$177.5k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,100 shares
@ $818.8, valued at
$900.7k
Exercised 1,100 options to buy
@ $372.46, valued at
$409.7k
|
|
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,100 shares
@ $721.86, valued at
$794k
Exercised 1,100 options to buy
@ $372.46, valued at
$409.7k
|
|
| 12/20/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 2,973 shares
@ $0
Granted 10,971 options to buy
@ $726.53, valued at
$8M
|
|
| 12/13/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 274 shares
@ $753.28, valued at
$206.4k
Sold 264 shares
@ $730.17, valued at
$192.8k
|
|
| 12/02/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,100 shares
@ $756.19, valued at
$831.8k
Exercised 1,100 options to buy
@ $372.46, valued at
$409.7k
|
|
| 11/07/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,000 shares
@ $727.82, valued at
$727.8k
Exercised 1,000 options to buy
@ $372.46, valued at
$372.5k
|
|
| 10/05/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 600 shares
@ $705.39, valued at
$423.2k
Sold 500 shares
@ $705.39, valued at
$352.7k
Exercised 500 options to buy
@ $342.93, valued at
$171.5k
Exercised 600 options to buy
@ $372.46, valued at
$223.5k
|
|
| 09/02/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,100 shares
@ $577.62, valued at
$635.4k
Exercised 1,100 options to buy
@ $342.93, valued at
$377.2k
|
|
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,000 shares
@ $701.82, valued at
$701.8k
Exercised 1,000 options to buy
@ $342.93, valued at
$342.9k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,000 shares
@ $607.46, valued at
$607.5k
Exercised 1,000 options to buy
@ $342.93, valued at
$342.9k
|
|
| 01/05/2022 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,000 shares
@ $625, valued at
$625k
Exercised 1,000 options to buy
@ $342.93, valued at
$342.9k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,000 shares
@ $640, valued at
$640k
Exercised 1,000 options to buy
@ $342.93, valued at
$342.9k
|
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|